Amide Local Anesthetics — MCQs
Which local anesthetic is considered the most cardiotoxic?
A patient presented with rigidity, tremors, and trismus after being administered an anesthetic agent. Which anesthetic agent is most likely to have been administered?
Which local anesthetic has the highest protein binding capacity?
Which anaesthetic belongs to the ester group?
What is the mechanism of action of local anesthetics?
Which of the following inhalation anesthetic agents is hepatotoxic?
Which of the following is FALSE about ropivacaine?
A young male was administered regional anesthesia with 0.25% bupivacaine. The patient became unresponsive, and the pulse became unrecordable. What is the best management in this situation?
Which is correct about the anesthetic drugs X and Y in the image shown? (Recent NEET Pattern 2016-17)
Which of the following is not an amide local anesthetic?
Amide Local Anesthetics Indian Medical PG Practice Questions and MCQs
Question 1: Which local anesthetic is considered the most cardiotoxic?
- A. Procaine
- B. Prilocaine
- C. Ropivacaine
- D. Bupivacaine (Correct Answer)
Explanation: ***Bupivacaine*** - **Bupivacaine** is an amide-type local anesthetic associated with significant **cardiotoxicity** due to its high lipid solubility and slow dissociation from cardiac sodium channels. - This can lead to severe **arrhythmias** and myocardial depression, making it particularly dangerous in systemic overdose. *Procaine* - **Procaine** is an ester-type local anesthetic with a relatively low potential for cardiotoxicity. - Its rapid metabolism by **plasma pseudocholinesterase** limits systemic exposure and reduces the risk of cardiac effects. *Prilocaine* - **Prilocaine** is an amide-type local anesthetic that is generally less cardiotoxic than bupivacaine. - Its primary concern is the potential to cause **methemoglobinemia** at higher doses, a side effect not directly related to cardiotoxicity. *Ropivacaine* - **Ropivacaine** is an amide-type local anesthetic developed as an alternative to bupivacaine with a reduced cardiotoxicity profile. - It exhibits a more favorable **therapeutic index** for cardiac effects due to its chemical structure and faster dissociation from cardiac sodium channels.
Question 2: A patient presented with rigidity, tremors, and trismus after being administered an anesthetic agent. Which anesthetic agent is most likely to have been administered?
- A. Halothane (Correct Answer)
- B. Nitrous Oxide (N2O)
- C. Thiopentone sodium
- D. Etomidate
Explanation: ***Halothane*** - The combination of **rigidity**, **tremors**, and **trismus** after an anesthetic agent suggests **malignant hyperthermia (MH)**, a rare but life-threatening inherited condition. - **Halothane (and other volatile anesthetics)**, along with succinylcholine, are known triggers for malignant hyperthermia. *Nitrous Oxide (N2O)* - While an anesthetic agent, **nitrous oxide** is not a known trigger for **malignant hyperthermia**. - It works by modulating **NMDA receptors** and does not typically cause rigidity, tremors, or trismus as a side effect. *Thiopentone sodium* - **Thiopentone sodium** is a **barbiturate** anesthetic and is not associated with triggering **malignant hyperthermia**. - Its effects primarily involve potentiation of **GABA-A receptors**, leading to sedation and hypnosis. *Etomidate* - **Etomidate** is a short-acting intravenous anesthetic that is not a known trigger for **malignant hyperthermia**. - It is typically associated with minimal cardiovascular depression but can cause **adrenocortical suppression** with prolonged use.
Question 3: Which local anesthetic has the highest protein binding capacity?
- A. Tetracaine (Correct Answer)
- B. Procaine
- C. Lidocaine
- D. Prilocaine
Explanation: ***Tetracaine*** - **Tetracaine** has a very high protein binding capacity (around 80%), which correlates with its **long duration of action** and high potency. - High protein binding means less free drug is available to reach nerve membranes immediately, but it also provides a reservoir for sustained release, contributing to its prolonged anesthetic effect. *Lidocaine* - **Lidocaine** has an intermediate protein binding capacity (around 60-70%), making it a **medium-duration** local anesthetic. - Its protein binding is lower than tetracaine, hence it has a shorter clinical duration of action compared to tetracaine. *Prilocaine* - **Prilocaine** has a relatively low protein binding capacity (around 55%), leading to a **shorter duration of action** compared to lidocaine and tetracaine. - Its lower protein binding also contributes to its relatively lower potency. *Procaine* - **Procaine** has the lowest protein binding capacity among the listed options (around 5-10%), making it a **short-acting** local anesthetic. - Its rapid metabolism by plasma pseudocholinesterases further contributes to its limited duration of action.
Question 4: Which anaesthetic belongs to the ester group?
- A. Lignocaine
- B. Propofol
- C. Procaine (Correct Answer)
- D. Benzocaine
Explanation: ***Procaine*** - **Procaine** is a classical **ester-type** local anesthetic, characterized by an ester linkage between the aromatic and amine parts of its chemical structure. - Ester-type local anesthetics are metabolized by **plasma pseudocholinesterase**, leading to a shorter duration of action compared to amides. *Benzocaine* - **Benzocaine** is also an ester local anesthetic, but it is typically used topically due to its poor water solubility and absorption. - While an ester, the question implies a common injectable agent, making procaine a more representative answer for the "ester group" in general anesthetic use. *Lignocaine* - **Lignocaine** (also known as lidocaine) is an **amide-type** local anesthetic, which can be identified by an amide linkage in its chemical structure. - Amide local anesthetics are primarily metabolized in the **liver** and generally have a longer duration of action than esters. *Propofol* - **Propofol** is a **short-acting intravenous general anesthetic** and is not classified as a local anesthetic or belonging to the ester group. - It works by potentiation of **GABA-A receptors** and is used for induction and maintenance of general anesthesia.
Question 5: What is the mechanism of action of local anesthetics?
- A. Block chloride channels
- B. Block calcium channels
- C. Block sodium channels (Correct Answer)
- D. Block potassium channels
Explanation: ***Block sodium channels*** - Local anesthetics work by **reversibly binding** to the alpha subunit of **voltage-gated sodium channels** on the neuronal membrane. - This binding prevents the influx of sodium ions, thereby inhibiting the **depolarization** of the neuron and **propagation of action potentials**. *Block chloride channels* - **Chloride channels** are primarily involved in **hyperpolarization** or stabilization of the resting membrane potential, and their blockade is not the primary mechanism of local anesthesia. - Drugs like **benzodiazepines** modulate GABA-gated chloride channels for their anxiolytic and sedative effects. *Block calcium channels* - **Calcium channels** are important for neurotransmitter release and muscle contraction, but their blockade is not the way local anesthetics exert their effects. - **Calcium channel blockers** are used in cardiovascular medicine (e.g., diltiazem, verapamil) to reduce heart rate and blood pressure. *Block potassium channels* - **Potassium channels** are crucial for repolarization of the neuronal membrane and maintaining the resting potential. - While some toxins block potassium channels, it is not the principal mechanism by which **local anesthetics** achieve their nerve blocking effect.
Question 6: Which of the following inhalation anesthetic agents is hepatotoxic?
- A. Halothane (Correct Answer)
- B. Sevoflurane
- C. Isoflurane
- D. Desflurane
Explanation: ***Halothane*** - **Halothane** is known for its potential to cause **halothane hepatitis**, a severe and sometimes fatal form of liver damage. - This toxicity is typically due to the formation of reactive metabolites during its metabolism, which can lead to immune-mediated liver injury. *Sevoflurane* - **Sevoflurane** is generally considered to have a very low risk of hepatotoxicity. - While it can produce a small amount of inorganic fluoride, which was a concern with older halogenated anesthetics, its metabolic profile makes it much safer for the liver compared to halothane. *Isoflurane* - **Isoflurane** is metabolized to a very small extent (less than 0.2%), significantly reducing the risk of generating toxic metabolites that could harm the liver. - It is commonly used in clinical practice due to its favorable safety profile, including minimal hepatotoxicity. *Desflurane* - **Desflurane** has an even lower metabolism rate than Isoflurane, making it one of the safest inhaled anesthetics in terms of liver toxicity. - Its rapid onset and offset properties, coupled with its minimal metabolism, contribute to its low potential for hepatotoxic effects.
Question 7: Which of the following is FALSE about ropivacaine?
- A. More cardiotoxic than lignocaine
- B. Contains only R enantiomer (Correct Answer)
- C. Less cardiotoxic than bupivacaine
- D. Onset of action is faster than bupivacaine
Explanation: ***Contains only R enantiomer*** - Ropivacaine is a **pure S-enantiomer** (S-(-)-enantiomer) preparation, NOT the R-enantiomer. - This single enantiomer formulation contributes to its **reduced cardiotoxicity** and improved safety profile compared to racemic bupivacaine. - The statement "contains only R enantiomer" is **FALSE** - this is the correct answer. *Less cardiotoxic than bupivacaine* - Ropivacaine has **lower lipid solubility** and faster dissociation from cardiac sodium channels compared to bupivacaine. - This results in **significantly reduced cardiotoxicity**, making it safer for large-volume regional blocks. - This statement is **TRUE**. *More cardiotoxic than lignocaine* - Ropivacaine is indeed **more cardiotoxic than lidocaine** due to its greater potency and longer duration of action. - Amide local anesthetics with higher potency (bupivacaine > ropivacaine > lidocaine) carry greater cardiac risk. - This statement is **TRUE**. *Onset of action is faster than bupivacaine* - Ropivacaine and bupivacaine have **similar onset times** (10-15 minutes for epidural/nerve blocks). - Both have similar pKa values (ropivacaine 8.1, bupivacaine 8.1), resulting in comparable onset characteristics. - While ropivacaine may have marginally faster onset in some contexts, clinically they are considered equivalent. - This statement is generally **FALSE or equivocal**, making it potentially the second-best answer, but the R-enantiomer statement is definitively false.
Question 8: A young male was administered regional anesthesia with 0.25% bupivacaine. The patient became unresponsive, and the pulse became unrecordable. What is the best management in this situation?
- A. ECPR with calcium
- B. ECPR with dobutamine
- C. ECPR with 20% intralipid (Correct Answer)
- D. ECPR with sodium bicarbonate
Explanation: ***ECPR with 20% intralipid*** - The scenario describes **Local Anesthetic Systemic Toxicity (LAST)**, likely due to bupivacaine, leading to cardiovascular collapse. - **Intralipid 20%** is the first-line treatment for LAST-induced cardiovascular toxicity, as it acts as a lipid sink for the lipophilic local anesthetic. *ECPR with calcium* - While calcium may be used in certain cardiac arrest scenarios, it is **not the primary treatment for bupivacaine-induced cardiovascular collapse** and LAST. - Calcium might offer some cardiac support but does not directly neutralize the local anesthetic's toxic effects. *ECPR with dobutamine* - **Dobutamine is an inotropic agent** used to improve cardiac contractility but is not indicated as a primary rescue therapy for severe LAST. - It would not address the underlying toxicity caused by bupivacaine and could potentially worsen the situation by increasing myocardial oxygen demand without reversing toxin effects. *ECPR with sodium bicarbonate* - **Sodium bicarbonate** is used to treat metabolic acidosis and can be beneficial in certain drug overdoses to enhance excretion or stabilize cardiac membranes. - However, it is **not the primary or most effective treatment for bupivacaine-induced LAST** and cardiovascular collapse compared to lipid emulsion therapy.
Question 9: Which is correct about the anesthetic drugs X and Y in the image shown? (Recent NEET Pattern 2016-17)
- A. Drug X and Y have equally fast onset of action
- B. Drug X and Y have equally fast onset of action but potency of X is more than Y
- C. Drug Y is more fast acting than X
- D. Drug X is more fast acting than Y (Correct Answer)
Explanation: ***Drug X is more fast acting than Y*** - The **oil:gas partition coefficient** for Drug X is lower than for Drug Y. A lower oil:gas partition coefficient typically correlates with a **faster onset of action** for inhaled anesthetics as it indicates lower solubility in blood and tissues, allowing for quicker equilibration in the brain. - While MAC is plotted against oil:gas partition coefficient, the question specifically asks about **onset of action**, which is primarily influenced by blood-gas solubility rather than oil-gas solubility. However, an anesthetic with lower oil-gas solubility (like X) would generally also have lower blood-gas solubility, leading to faster onset. *Drug Y is more fast acting than X* - Drug Y has a **higher oil:gas partition coefficient** compared to Drug X, indicating greater lipid solubility. - A higher oil:gas partition coefficient generally correlates with a **slower onset of action** for inhaled anesthetics, as more drug dissolves in lipids before reaching the brain. *Drug X and Y have equally fast onset of action* - The graph clearly shows that Drug X and Drug Y have different **oil:gas partition coefficients**. - Since the partition coefficients are different, their **solubility characteristics** and therefore their clinical onset of action would also be different. *Drug X and Y have equally fast onset of action but potency of X is more than Y* - Onset of action is **not equal** for X and Y due to their differing oil:gas partition coefficients. - Potency, represented by **MAC** (Minimum Alveolar Concentration), is inversely related to the oil:gas partition coefficient for many inhaled anesthetics. From the graph, Drug X has a higher MAC value than Drug Y (meaning it is **less potent** but acts faster).
Question 10: Which of the following is not an amide local anesthetic?
- A. Prilocaine
- B. Bupivacaine
- C. Lignocaine
- D. Cocaine (Correct Answer)
Explanation: ***Cocaine*** - **Cocaine** is an **ester-type** local anesthetic, not an amide. Ester local anesthetics are characterized by an **ester bond** in their chemical structure. - It works by blocking nerve impulse transmission and also by **inhibiting norepinephrine reuptake**, contributing to its vasoconstrictive and stimulatory effects. *Lignocaine* - **Lignocaine** (also known as **lidocaine**) is an **amide-type** local anesthetic, characterized by an **amide bond** in its chemical structure. - Amide local anesthetics are generally more stable and have a longer duration of action compared to ester types. *Prilocaine* - **Prilocaine** is an **amide-type** local anesthetic, commonly used in dentistry and for regional anesthesia. - Its amide structure contributes to its stability and intermediate duration of action. *Bupivacaine* - **Bupivacaine** is an **amide-type** local anesthetic known for its relatively long duration of action and potency. - It is often used for epidural anesthesia and nerve blocks due to its prolonged effect.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free